Lilly's Obesity Pill Draws 1,390 US Prescriptions in Launch Week

Lilly weight-loss pill Foundayo shows strong first-week demand

Foundayo was approved in the U.S. on April 1, with prescriptions accepted immediately on LillyDirect, while shipping started on April 6.

Eli Lilly’s GLP-1 pill hit nearly 1,400 prescriptions in first week

Novo’s pill had a stronger first week than Lilly’s, with its Wegovy pill hitting 3,071 US prescriptions in the first four days after its launch on January 5.

Lilly's obesity pill draws 1,390 US prescriptions in launch week

Lilly weight loss pill prescriptions near 1,400 (LLY:NYSE)

Eli Lilly (LLY) stock is in focus as U.S. prescriptions for the company's new weight loss pill, Foundayo, reach 1,390 in its debut week. Read more here.